Skip to main content
FDA allows continued sale of breast implants linked to cancer

The FDA announced it will permit continued sales of textured breast implants, which were recently tied to breast-implant-associated anaplastic large cell lymphoma. However, the agency may consider adding a black box warning and is working with patient groups and manufacturers on label changes.

Full Story: